Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Non-Current Liabilities (2023)

Upstream Bio has reported Total Non-Current Liabilities over the past 1 years, most recently at $6.5 million for Q4 2023.

  • Quarterly results put Total Non-Current Liabilities at $6.5 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $6.5 million (changed N/A YoY), and the annual figure for FY2023 was $6.5 million, changed.
  • Total Non-Current Liabilities for Q4 2023 was $6.5 million at Upstream Bio.
  • Over the last five years, Total Non-Current Liabilities for UPB hit a ceiling of $6.5 million in Q4 2023 and a floor of $6.5 million in Q4 2023.